Zantac 150 mg recall: Nitrosamine Impurity
Zantac 150 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC's 66715-9736-2 66715-9736-3 66715-9736-8
Why was Zantac 150 mg recalled?
CGMP Deviations: Presence of NDMA impurity detected in product.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
all lots
- Product
- Zantac 150 mg, Distributed by: Chattem, Inc., a Sanofi Company P.O. Box 2219, Chattanooga, TN 37409-0219. NDC's 66715-9736-2 66715-9736-3 66715-9736-8
- Recalling firm
- Sanofi-Aventis U.S. LLC
- Distribution
- Nationwide
- Recall date
- December 11, 2019
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (drug)